Know Your Myeloma Therapy: What's Available for Maintenance Therapy?
While maintenance therapy is not a new concept for many myeloma community members, new maintenance therapy regimens are being approved. And, as always, the constant question remains, "How long do I need to stay on this therapy?"
Dr. Ayo Fatoki shares upcoming research and his speciality center's practice on maintenance therapy regimens and durations.
Type your questions in the chat and we will answer them!
Audrey introduces the agenda of the event and featured speaker Dr. Ayo Fatoki.
Dr. Ayo Fatoki shares upcoming research and his speciality center's practice on maintenance therapy regimens and durations.
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Raleigh Ayo Fatoki, MD, MBA
Raleigh Ayo Fatoki, MD, MBA is a Hematology-Oncology fellow at the University Miami-Sylvester Comprehensive Cancer Center. His research interests include Multiple Myeloma and the biological drivers of disparities in people of African descent. Dr. Fatoki studied Economics at Howard University before completing a joint MD/MBA program at Meharry Medical College and Vanderbilt University Owen Graduate School of Management. He trained in Internal Medicine with Kaiser Permanente in Oakland, CA.